577 related articles for article (PubMed ID: 17304350)
1. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
[TBL] [Abstract][Full Text] [Related]
2. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
[TBL] [Abstract][Full Text] [Related]
3. CHIP-ping away at tau.
Goryunov D; Liem RK
J Clin Invest; 2007 Mar; 117(3):590-2. PubMed ID: 17332887
[TBL] [Abstract][Full Text] [Related]
4. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
Kumar P; Jha NK; Jha SK; Ramani K; Ambasta RK
J Alzheimers Dis; 2015; 43(2):341-61. PubMed ID: 25096626
[TBL] [Abstract][Full Text] [Related]
5. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
Sahara N; Murayama M; Mizoroki T; Urushitani M; Imai Y; Takahashi R; Murata S; Tanaka K; Takashima A
J Neurochem; 2005 Sep; 94(5):1254-63. PubMed ID: 16111477
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 activator Aha1 drives production of pathological tau aggregates.
Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
[TBL] [Abstract][Full Text] [Related]
7. Hsp multichaperone complex buffers pathologically modified Tau.
Moll A; Ramirez LM; Ninov M; Schwarz J; Urlaub H; Zweckstetter M
Nat Commun; 2022 Jun; 13(1):3668. PubMed ID: 35760815
[TBL] [Abstract][Full Text] [Related]
8. Tau triage decisions mediated by the chaperone network.
Cook C; Petrucelli L
J Alzheimers Dis; 2013; 33 Suppl 1():S145-51. PubMed ID: 22596270
[TBL] [Abstract][Full Text] [Related]
9. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.
Hatakeyama S; Matsumoto M; Kamura T; Murayama M; Chui DH; Planel E; Takahashi R; Nakayama KI; Takashima A
J Neurochem; 2004 Oct; 91(2):299-307. PubMed ID: 15447663
[TBL] [Abstract][Full Text] [Related]
10. Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation.
Cook C; Gendron TF; Scheffel K; Carlomagno Y; Dunmore J; DeTure M; Petrucelli L
Hum Mol Genet; 2012 Jul; 21(13):2936-45. PubMed ID: 22492994
[TBL] [Abstract][Full Text] [Related]
11. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies.
Luo W; Dou F; Rodina A; Chip S; Kim J; Zhao Q; Moulick K; Aguirre J; Wu N; Greengard P; Chiosis G
Proc Natl Acad Sci U S A; 2007 May; 104(22):9511-6. PubMed ID: 17517623
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ
Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
Kim E; Sakata K; Liao FF
PLoS Genet; 2017 Jul; 13(7):e1006849. PubMed ID: 28678786
[TBL] [Abstract][Full Text] [Related]
14. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation.
Petrucelli L; Dickson D; Kehoe K; Taylor J; Snyder H; Grover A; De Lucia M; McGowan E; Lewis J; Prihar G; Kim J; Dillmann WH; Browne SE; Hall A; Voellmy R; Tsuboi Y; Dawson TM; Wolozin B; Hardy J; Hutton M
Hum Mol Genet; 2004 Apr; 13(7):703-14. PubMed ID: 14962978
[TBL] [Abstract][Full Text] [Related]
15. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.
Shimura H; Schwartz D; Gygi SP; Kosik KS
J Biol Chem; 2004 Feb; 279(6):4869-76. PubMed ID: 14612456
[TBL] [Abstract][Full Text] [Related]
16. Involvement of endoplasmic reticulum stress in tauopathy.
Sakagami Y; Kudo T; Tanimukai H; Kanayama D; Omi T; Horiguchi K; Okochi M; Imaizumi K; Takeda M
Biochem Biophys Res Commun; 2013 Jan; 430(2):500-4. PubMed ID: 23237806
[TBL] [Abstract][Full Text] [Related]
17. Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes.
Saidi LJ; Polydoro M; Kay KR; Sanchez L; Mandelkow EM; Hyman BT; Spires-Jones TL
J Alzheimers Dis; 2015; 44(3):937-47. PubMed ID: 25374103
[TBL] [Abstract][Full Text] [Related]
18. Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes.
Woo JA; Liu T; Zhao X; Trotter C; Yrigoin K; Cazzaro S; Narvaez E; Khan H; Witas R; Bukhari A; Makati K; Wang X; Dickey C; Kang DE
Hum Mol Genet; 2017 Oct; 26(20):3973-3988. PubMed ID: 29016855
[TBL] [Abstract][Full Text] [Related]
19. Akt and CHIP coregulate tau degradation through coordinated interactions.
Dickey CA; Koren J; Zhang YJ; Xu YF; Jinwal UK; Birnbaum MJ; Monks B; Sun M; Cheng JQ; Patterson C; Bailey RM; Dunmore J; Soresh S; Leon C; Morgan D; Petrucelli L
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3622-7. PubMed ID: 18292230
[TBL] [Abstract][Full Text] [Related]
20. Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome.
Opattova A; Filipcik P; Cente M; Novak M
J Alzheimers Dis; 2013; 33(2):339-48. PubMed ID: 22936006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
